| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731545 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PDP1 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of PDP1 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731545 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PDP1 mRNA | CTD | PMID:20106945 PMID:21632981 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:620393 | 6480464 | 2,4-dinitrotoluene affects the expression of PDP1 mRNA | CTD | PMID:21346803 |
| ammonium chloride | affects expression | ISO | RGD:620393 | 6480464 | Ammonium Chloride affects the expression of PDP1 mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of PDP1 mRNA; more ... | CTD | PMID:21715664 |
| benzo[a]pyrene | decreases expression | ISO | RGD:620393 | 6480464 | Benzo(a)pyrene results in decreased expression of PDP1 mRNA | CTD | PMID:21839799 |
| calcitriol | decreases expression | ISO | RGD:731545 | 6480464 | Calcitriol results in decreased expression of PDP1 mRNA | CTD | PMID:16002434 |
| choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PDP1 mRNA | CTD | PMID:20938992 |
| copper atom | multiple interactions | ISO | RGD:731545 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of PDP1 mRNA | CTD | PMID:20971185 |
| copper atom | increases expression | ISO | RGD:620393 | 6480464 | Copper results in increased expression of PDP1 mRNA | CTD | PMID:22465980 |
| copper(0) | multiple interactions | ISO | RGD:731545 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of PDP1 mRNA | CTD | PMID:20971185 |
| copper(0) | increases expression | ISO | RGD:620393 | 6480464 | Copper results in increased expression of PDP1 mRNA | CTD | PMID:22465980 |
| copper(2+) sulfate | increases expression | ISO | RGD:731545 | 6480464 | Copper Sulfate results in increased expression of PDP1 mRNA | CTD | PMID:19549813 |
| coumestrol | decreases expression | ISO | RGD:731545 | 6480464 | Coumestrol results in decreased expression of PDP1 mRNA | CTD | PMID:19167446 |
| crocidolite asbestos | increases expression | ISO | RGD:731545 | 6480464 | Asbestos, Crocidolite results in increased expression of PDP1 mRNA | CTD | PMID:18687144 |
| cyclosporin A | increases expression | ISO | RGD:731545 | 6480464 | Cyclosporine results in increased expression of PDP1 mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | ISO | RGD:731545 | 6480464 | Cyclosporine results in decreased expression of PDP1 mRNA | CTD | PMID:22147139 |
| D-glucose | multiple interactions | ISO | RGD:620393 | 6480464 | [Dexamethasone results in decreased oxidation of Glucose] which results in increased phosphorylation of and results in decreased activity of PDP1 protein | CTD | PMID:20181797 |
| dexamethasone | multiple interactions | ISO | RGD:620393 | 6480464 | [Dexamethasone results in decreased oxidation of Glucose] which results in increased phosphorylation of and results in decreased activity of PDP1 protein; more ... | CTD | PMID:20181797 |
| dibutyl phthalate | increases expression | ISO | RGD:620393 | 6480464 | Dibutyl Phthalate results in increased expression of PDP1 mRNA | CTD | PMID:21266533 |
| folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PDP1 mRNA | CTD | PMID:20938992 |
| glucose | multiple interactions | ISO | RGD:620393 | 6480464 | [Dexamethasone results in decreased oxidation of Glucose] which results in increased phosphorylation of and results in decreased activity of PDP1 protein | CTD | PMID:20181797 |
| hydrogen peroxide | increases expression | ISO | RGD:731545 | 6480464 | Hydrogen Peroxide results in increased expression of PDP1 mRNA | CTD | PMID:18951874 |
| indomethacin | decreases expression | ISO | RGD:731545 | 6480464 | Indomethacin results in decreased expression of PDP1 mRNA | CTD | PMID:16984733 |
| L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PDP1 mRNA | CTD | PMID:20938992 |
| methapyrilene | increases expression | ISO | RGD:620393 | 6480464 | Methapyrilene results in increased expression of PDP1 mRNA | CTD | PMID:16393664 |
| N-ethyl-N-nitrosourea | increases expression | ISO | RGD:620393 | 6480464 | Ethylnitrosourea results in increased expression of PDP1 mRNA | CTD | PMID:15954086 |
| nicotinamide | multiple interactions | ISO | RGD:620393 | 6480464 | Niacinamide inhibits the reaction [Dexamethasone results in increased phosphorylation of PDP1 protein] | CTD | PMID:20181797 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of PDP1 mRNA | CTD | PMID:17562736 |
| perfluorooctanoic acid | increases expression | ISO | RGD:620393 | 6480464 | perfluorooctanoic acid results in increased expression of PDP1 mRNA | CTD | PMID:19162173 |
| progesterone | decreases expression | ISO | RGD:731545 | 6480464 | Progesterone results in decreased expression of PDP1 mRNA | CTD | PMID:18037150 |
| quercetin | affects expression | ISO | RGD:731545 | 6480464 | Quercetin affects the expression of PDP1 mRNA | CTD | PMID:21632981 |
| raloxifene | multiple interactions | ISO | RGD:731545 | 6480464 | [Raloxifene co-treated with ESR2 protein] results in increased expression of PDP1 mRNA | CTD | PMID:19059307 |
| tamoxifen | multiple interactions | ISO | RGD:731545 | 6480464 | [Tamoxifen co-treated with ESR2 protein] results in increased expression of PDP1 mRNA | CTD | PMID:19059307 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:731545 | 6480464 | tert-Butylhydroperoxide results in increased expression of PDP1 mRNA | CTD | PMID:15336504 |
| testosterone enanthate | affects expression | ISO | RGD:731545 | 6480464 | testosterone enanthate affects the expression of PDP1 mRNA | CTD | PMID:17440010 |
| tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of PDP1 mRNA | CTD | PMID:17484886 |
| zinc atom | increases expression | ISO | RGD:620393 | 6480464 | Zinc results in increased expression of PDP1 mRNA | CTD | PMID:17074742 |
| zinc sulfate | increases expression | ISO | RGD:620393 | 6480464 | Zinc Sulfate results in increased expression of PDP1 mRNA | CTD | PMID:17074742 |
| zinc(0) | increases expression | ISO | RGD:620393 | 6480464 | Zinc results in increased expression of PDP1 mRNA | CTD | PMID:17074742 |